PuraPharm

Our mission is to harmonize traditional herbal medicines with 21 century technologies to improve the health and well-being of society. Research, development and manufacturing of standardized botanical extracts. Contract manufacturing of natural health products, dietary supplements and nutraceuticals. We proudly provide customers with advanced research, development and manufacturing services supported by our state-of-the-art manufacturing facilities and highly experienced team of scientists and experts. At CPC, we believe our deep roots in scientific innovation has established us as the premier organisation in providing top quality natural health products formulated with the ever evolving technology of the 21st century. At CPC, we believe quality products derive from quality people.

We are proud to offer our customers a seamless end-to-end customer experience, employing experienced pharmacists to provide assistance with everything from registration documentation to production needs and package marketing design. Ltd, Shanghai, is a leading developer, manufacturer and distributor of generic pharmaceuticals, medical supplies and veterinary products. We have more than 30 years’ experience delivering the highest standards in quality, value and service to our China-based and international customers. Ltd, Shanghai, produces and distributes more than 500 pharmaceutical products from its local facilities, including specialized drugs for a range of different therapeutic applications. Ltd, Shanghai, upholds the demanding standards and international requirements and our manufacturing and partner facilities are required to hold GMP (Good Manufacturing Practices), GSP (Good Supply Practices) or ISO (International Organization for Standardization) certification. Ltd is an established global manufacturer and supplier of generic pharmaceuticals, nutraceuticals, and medical supplies and is located in the Pearl of the Orient, Shanghai China. Ltd is the preferred provider of generic pharmaceuticals, nutritional supplements, and medical supplies to NGO’s, Aid Organizations, Private companies, and Government Agencies around the world. We strive to supply high quality, professional medical products around the world at a competitive price.

We are committed to providing the highest quality services to drug discovery companies addressing worldwide healthcare needs. The world’s top pharmaceuticals companies and institutes are also our partners. We have been tested to meet time sensitive deadlines supporting critical clinical trials. We leverage our significant scientific foundation to maximize the collaborative value with our partners. With 25,000m2 of R&D laboratory space distributed over 4 sites throughout China, our partners gain the maximum flexibility in leveraging our services in medicinal chemistry SAR development, synthetic route scouting, process optimization, and production to multi-ton scale.

Hansoh Pharma, a top-ranked pharmaceutical company driven by innovation, headquartered in Greater China, is committed to improving human health through continuous innovation, focusing mainly on the fields of oncology, anti-infections, CNS diseases, metabolic diseases, as well as autoimmune diseases. Hansoh Pharma is highly efficient in discovering innovative macromolecule and small-molecule drugs, and its R&D efforts cover the fields of monoclonal and bispecific antibodies, ADC, siRNA, and fusion protein products. Hansoh Pharma has so far marketed 7 innovative drugs, and has more than 30 innovative drug programs at different clinical stages with over 40 clinical trials currently in progress, forming a competitive pipeline. Our innovative drugs on the market include: Saint Luolai (Pegmolesatide Injection）, Globally Unique Erythropoietin Mimetic Peptide(EMP) ; Ameile (aumolertinib mesylate tablets), China's first original third-generation EGFR-TKI innovative drug; XINYUE (inebilizumab injections), the world's only humanized anti-CD19 monoclonal antibody approved for the treatment of adult patients with AQP4 antibody-positive NMOSD; Hengmu (tenofovir amibufenamide tablets), China's first original oral anti-HBV drug; Hansoh Xinfu (flumatinib mesylate tablets), China's first original second-generation innovative drug for chronic myeloid leukemia; Fulaimei (PEG-loxenatide for injection), China's first original long-acting GLP-1 hypoglycemic drug and the world's first PEGylated long-acting hypoglycemic drug; and Mailingda (morinidazole sodium chloride injection), the world's first innovative nitroimidazole anti-anaerobic drug in 40 years. Seven innovative drugs have been included in the National Reimbursement Drug List, and Hansoh Pharma has successfully transformed itself into an innovative biopharma company. Our production quality system has been officially certified by FDA in the United States, EMA of the European Union, and PMDA in Japan, and finished preparations and APIs have been approved for marketing in Europe, America, Japan, etc.

PurCann Pharma specializes in the manufacturing and commercialization of cannabinoid-rich extracts from hemp and cannabis grown in Canada. PurCann Pharma also offers Toll and Contract manufacturing services (CMO), Private Label, R&D, extraction, purification, and packaging services. PurCann Pharma also offers Toll and Contractmanufacturing services, Private Label, R&D,extraction, purification, and packaging services.PurCann Pharma is fully licensed by Health Canadato carry out Cannabis processing, and R&D.PurCann Pharma has applied for a medical licenseand is currently awaiting its approval. The state-of-the-art factory, built in 2009 and further expanded in 2019, now occupies more than 45,000 ft2, including 9,000 ft2 of laboratories and 20,000 ft2 of manufacturing and packaging space - a total investment of $45 million. An additional 4,300 ft2 dedicated to packaging has been built in 2021. The site is ISO 9001:2015 certified and follows Health Canada's Cannabis Regulations Good Production Practices (GPP). PurCann Pharma has entered into hemp and cannabis supply agreements with producers who are committed to providing high quality products. Producers must provide Certificates of Analysis (COA) attesting that their products respect all Health Canada criteria regarding cannabinoid concentration, microbial counts, heavy metals levels, pesticides residues, etc.

We provide full service, industry-leading manufacturing capabilities from exclusive formulation, development, production, laboratory testing, storage, and delivery to product management. We are proud to maintain the highest standards in our work when our efforts led us in gaining over 550 MAL approvals as granted by National Pharmaceutical Regulatory Agency (NPRA). Our services include exclusive formulation development services, product research and development, regulatory and laboratory testing services. We strive to provide customers with superior, efficacious products through innovative methodologies and specially selected suppliers that result in wellness for all. Establish and adhere to guideline for product quality and end user consumption. Attention to details and pursuit of perfection in making products safe, pure and effective. Incorporate technologies to address food safety and biologically complex products. Yanling Natural Hygiene founded as Traditional Medicine manufacturer in Segambut, Malaysia.